(Q28296761)
Statements
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling (English)
Scott M Wilhelm
Lila Adnane
Philippa Newell
1 October 2008
Identifiers
2 references
2 references